Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$1.12 - $3.73 $560 - $1,865
500 New
500 $1,000
Q4 2022

Feb 13, 2023

BUY
$5.19 - $13.5 $1,038 - $2,700
200 New
200 $1,000
Q3 2021

Nov 05, 2021

SELL
$13.16 - $22.47 $9,541 - $16,290
-725 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$19.57 - $26.32 $14,188 - $19,082
725 New
725 $16,000
Q1 2021

May 24, 2021

SELL
$17.58 - $32.59 $12,745 - $23,627
-725 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$10.99 - $20.4 $16,485 - $30,599
-1,500 Reduced 67.42%
725 $13,000
Q3 2020

Nov 16, 2020

BUY
$11.55 - $23.75 $25,698 - $52,843
2,225 New
2,225 $26,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.